Mayo Clinic Talks21 Joulu 2020

COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update

This episode was recorded on December 18, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)

It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines.

Additional Resources:

Mayo Clinic Vaccine Research Page https://www.mayo.edu/research/labs/vaccine-research-group/overview
Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education
https://www.sciencedirect.com/science/article/pii/S0264410X11011881
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(500)

Cardiovascular-Kidney-Metabolic (CKM) Syndrome

Host: Darryl S. Chutka, M.D. Guest: Regis Fernandes, M.D. We’ve known for some time that patients who have hypertension and diabetes are at increased risk for developing subsequent cardiovascular di...

30 Kesä 29min

Common Pickleball Injuries

Host: Darryl S. Chutka, M.D. Guest: Joshua M. Romero, M.D. Pickleball has become one of the fastest growing sports in the U.S., especially among older adults. This rapid rise in popularity has also ...

23 Kesä 26min

Vector-Borne Illnesses

Host: Darryl S. Chutka, M.D. Guest: Stacey Rizza, M.D. Although vector-borne illnesses can be acquired by travel to distant parts of the world, some can be acquired here in the U.S. As a result, the...

18 Kesä 21min

Update on Lyme Disease

Host: Darryl S. Chutka, M.D. Guest: Stacey Rizza, M.D. Lyme Disease is a tick-borne illness commonly seen in various parts of the country. Despite its common occurrence in the primary care practice,...

16 Kesä 28min

Ebola Virus

Host: Darryl S. Chutka, M.D. Guest: Stacey Rizza, M.D. We’ve now had our second outbreak of a potentially deadly infectious disease. Hantavirus has been diagnosed in several individuals and most rec...

9 Kesä 31min

Addiction Care & Empowering the Non-Specialist

Host: Darryl S. Chutka, M.D. Guest: Benjamin Lai, M.D. Substance use disorders are chronic and often relapsing conditions associated with compulsive substance use. They result from a complex interac...

2 Kesä 28min

Fibromyalgia

Host: Darryl S. Chutka, M.D. Guest: Michael Mueller, M.D. Fibromyalgia is a chronic health problem commonly seen in a primary care setting. It can be challenging to diagnose and even more so to mana...

26 Touko 33min

Bladder Cancer

Host: Darryl S. Chutka, M.D Guest: Mark D. Tyson, III, M.D., M.P.H. Bladder cancer is one of the most common malignancies worldwide, and primary care clinicians are often the first to evaluate patie...

21 Touko 28min